Literature DB >> 15213075

Partial cardiac autotransplantation for reduction of the left atrium.

Hasan B Erdoğan1, Kaan Kirali, Suat N Omeroğlu, Deniz Göksedef, Omer Işik, Cevat Yakut.   

Abstract

Various surgical procedures have been employed to treat a greatly enlarged left atrium. We review the use of partial cardiac autotransplantation to reduce left atrial volume in 7 patients with rheumatic mitral valve disease and left atrial and ventricular volume in 2 patients with idiopathic dilated cardiomyopathy. There were 5 males and 4 females aged 25 to 62 years. The patients with rheumatic etiology had atrial fibrillation, while those with dilated cardiomyopathy had sinus rhythm. The mitral valve was replaced in 6 patients and reconstructed in 3. Mean aortic cross clamp time in the operations involving isolated left atrial resection was 119 +/- 44 min. Mean left atrial volume fell from 331 mL to 92 mL, while mean left atrial diameter decreased from 8.6 cm to 4.7 cm. Sinus rhythm was restored in 5 of the 7 patients who had preoperative atrial fibrillation. There was no operative mortality. The patients with dilated cardiomyopathy died in the postoperative period, one on the 14th day from low cardiac output and the other on the 113th day from multiorgan failure. Partial cardiac autotransplantation can be effective in reducing heart chamber size in selected patients, especially those with giant left atrium.

Entities:  

Mesh:

Year:  2004        PMID: 15213075     DOI: 10.1177/021849230401200206

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  2 in total

1.  Partial cardiac autotransplantation with a concomitant mitral valve, aortic valve replacement and tricuspid plasty.

Authors:  Jun Pan; Qing-Guo Li; Jie Li; Dong-Jin Wang
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07-17

2.  Cardiac autotransplantation and ex vivo surgical repair of giant left atrium: a case presentation.

Authors:  Zan Mitrev; Milka Klincheva; Tanja Anguseva; Igor Zdravkovski; Rodney Alexander Rosalia
Journal:  BMC Cardiovasc Disord       Date:  2018-12-18       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.